BIOMARKERS FOR OVARIAN CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 1, 2015
app pub date -
Dec 4, 2014
filing date -
Jun 11, 2012
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Biomarkers are provided that are useful for the detection or diagnosis of ovarian cancer. The biomarkers are also useful for determining whether the ovarian cancer is active, is in remission, or is recurring. Preferred biomarkers for detecting or diagnosing ovarian are provided in Table 1. Exemplary combinations of these biomarkers are described in FIGS. 2-6.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully